https://www.equitypandit.com/zydus-lifescience-gets-usfda-approval-for-neuromuscular-drug/
Zydus Lifesciences Limited on 6 October announced that it had received the final approval from the USFDA (the United States Food and Drug Administration) for its sugammadex injection, which is a post-surgery drug. The injection is used to reverse the effect o…
Create an account or login to join the discussion